CD248 and obesity disorder: CD248, which has been recently linked with insulin metabolism [46], NAD(P)H quinone dehydrogenase 1 (NQO1) and tenomodulin (TNMD) were downregulated following LIWL, and their expression was also reduced in SAT of individuals with or without obesity of the LATC and OA cohort.